SCMR expert consensus statement for cardiovascular magnetic resonance of patients with a cardiac implantable electronic device.
Autor: | Kim D; Department of Radiology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. Electronic address: daniel.kim3@northwestern.edu., Collins JD; Department of Radiology, Mayo Clinic, Rochester, MN, USA., White JA; Departments of Cardiac Sciences and Diagnostic Imaging, Cummings School of Medicine, University of Calgary, Calgary, Canada., Hanneman K; Department of Medical Imaging, University Medical Imaging Toronto, Toronto General Hospital and Peter Munk Cardiac Centre, University of Toronto, Toronto, Canada., Lee DC; Department of Medicine (Division of Cardiology), Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Patel AR; Cardiovascular Division, University of Virginia, Charlottesville, VA, USA., Hu P; School of Biomedical Engineering, ShanghaiTech University, Shanghai, China., Litt H; Department of Radiology, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, PA, USA., Weinsaft JW; Department of Medicine (Division of Cardiology), Weill Cornell Medicine, New York, NY, USA., Davids R; SHS AM NAM USA DI MR COLLAB ADV-APPS, Siemens Medical Solutions USA, Inc., Chicago, Il, USA., Mukai K; Salinas Valley Memorial Healthcare System, Ryan Ranch Center for Advanced Diagnostic Imaging, Monterey, CA, USA., Ng MY; Department of Diagnostic Radiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, the Hong Kong Special Administrative Region of China., Luetkens JA; Department of Diagnostic and Interventional Radiology, University Hospital Bonn, Venusberg-Campus 1, Bonn, Germany., Roguin A; Department of Cardiology, Hillel Yaffe Medical Center, Hadera and Faculty of Medicine. Technion - Israel Institute of Technology, Israel., Rochitte CE; Heart Institute, InCor, University of São Paulo Medical School, São Paulo, SP, Brazil., Woodard PK; Mallinckrodt Institute of Radiology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA., Manisty C; Institute of Cardiovascular Science, University College London, London, UK., Zareba KM; Division of Cardiovascular Medicine, The Ohio State University, Columbus, OH, USA., Mont L; Cardiovascular Institute, Hospital Clínic, University of Barcelona, Catalonia, Spain., Bogun F; Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, MI, USA., Ennis DB; Department of Radiology, Stanford University, Stanford, CA, USA., Nazarian S; Section of Cardiac Electrophysiology, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, PA, USA., Webster G; Department of Pediatrics (Cardiology), Ann & Robert H. Lurie Children's Hospital, Chicago, IL, USA., Stojanovska J; Department of Radiology, Grossman School of Medicine, New York University, New York, NY, USA. |
---|---|
Jazyk: | angličtina |
Zdroj: | Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance [J Cardiovasc Magn Reson] 2024 Summer; Vol. 26 (1), pp. 100995. Date of Electronic Publication: 2024 Jan 12. |
DOI: | 10.1016/j.jocmr.2024.100995 |
Abstrakt: | Cardiovascular magnetic resonance (CMR) is a proven imaging modality for informing diagnosis and prognosis, guiding therapeutic decisions, and risk stratifying surgical intervention. Patients with a cardiac implantable electronic device (CIED) would be expected to derive particular benefit from CMR given high prevalence of cardiomyopathy and arrhythmia. While several guidelines have been published over the last 16 years, it is important to recognize that both the CIED and CMR technologies, as well as our knowledge in MR safety, have evolved rapidly during that period. Given increasing utilization of CIED over the past decades, there is an unmet need to establish a consensus statement that integrates latest evidence concerning MR safety and CIED and CMR technologies. While experienced centers currently perform CMR in CIED patients, broad availability of CMR in this population is lacking, partially due to limited availability of resources for programming devices and appropriate monitoring, but also related to knowledge gaps regarding the risk-benefit ratio of CMR in this growing population. To address the knowledge gaps, this SCMR Expert Consensus Statement integrates consensus guidelines, primary data, and opinions from experts across disparate fields towards the shared goal of informing evidenced-based decision-making regarding the risk-benefit ratio of CMR for patients with CIEDs. Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. (Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |